ampelopsin has been researched along with Cancer of Cervix in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PN; Hsiao, YH; Hsin, MC; Lee, CY; Lin, CW; Wang, PH; Yang, SF | 1 |
1 other study(ies) available for ampelopsin and Cancer of Cervix
| Article | Year |
|---|---|
Dihydromyricetin Inhibited Migration and Invasion by Reducing S100A4 Expression through ERK1/2/β-Catenin Pathway in Human Cervical Cancer Cell Lines.
Topics: beta Catenin; Cell Movement; Female; Flavonols; HeLa Cells; Humans; MAP Kinase Signaling System; S100 Calcium-Binding Protein A4; Uterine Cervical Neoplasms | 2022 |